Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ligand Pharmaceuticals Inc (LGND) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ligand Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 886163.
Total stock buying since 2014: $3,768,647.
Total stock sales since 2014: $189,043,873.
Total stock option exercises since 2014: $26,702,538.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 11,010 | $1,154,044 | 3,868 | $472,656 | 4,812 | $251,666 |
2024 | 2,500 | $243,480 | 104,189 | $9,921,891 | 65,287 | $3,457,964 |
2023 | 4,000 | $237,528 | 17,560 | $1,350,441 | 12,816 | $120,598 |
2022 | 2,500 | $206,910 | 26,696 | $1,978,161 | 38,000 | $558,760 |
2021 | 0 | $0 | 254,898 | $45,649,827 | 334,153 | $8,039,802 |
2020 | 1,000 | $82,520 | 32,899 | $3,633,177 | 113,842 | $1,818,675 |
2019 | 17,802 | $1,831,729 | 6,591 | $668,694 | 61,800 | $1,133,382 |
2018 | 0 | $0 | 325,024 | $69,648,591 | 186,997 | $5,068,445 |
2017 | 0 | $0 | 192,032 | $23,226,551 | 81,858 | $1,253,468 |
2016 | 0 | $0 | 102,337 | $11,422,797 | 46,921 | $1,190,727 |
2015 | 0 | $0 | 231,566 | $21,071,087 | 160,254 | $3,809,051 |
2014 | 275 | $12,436 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-09 | 0 | $0 | 467 | $76,008 | 0 | $0 |
2025-08 | 0 | $0 | 467 | $61,586 | 0 | $0 |
2025-07 | 0 | $0 | 934 | $116,750 | 0 | $0 |
2025-06 | 0 | $0 | 1,000 | $114,312 | 0 | $0 |
2025-05 | 11,010 | $1,154,044 | 1,000 | $104,000 | 0 | $0 |
2025-04 | 0 | $0 | 0 | $0 | 2,406 | $125,833 |
2025-01 | 0 | $0 | 0 | $0 | 2,406 | $125,833 |
2024-11 | 0 | $0 | 2,406 | $297,501 | 2,406 | $125,833 |
2024-09 | 0 | $0 | 19,322 | $1,974,241 | 18,240 | $958,506 |
2024-08 | 2,500 | $243,480 | 38,603 | $3,942,613 | 2,253 | $126,318 |
2024-05 | 0 | $0 | 41,825 | $3,554,503 | 16,917 | $941,904 |
2024-04 | 0 | $0 | 0 | $0 | 5,299 | $239,672 |
2024-03 | 0 | $0 | 1,893 | $140,649 | 18,908 | $993,490 |
2024-02 | 0 | $0 | 140 | $12,384 | 1,264 | $72,241 |
2023-09 | 4,000 | $237,528 | 0 | $0 | 0 | $0 |
2023-05 | 0 | $0 | 17,260 | $1,329,464 | 12,816 | $120,598 |
2023-03 | 0 | $0 | 300 | $20,977 | 0 | $0 |
2022-12 | 0 | $0 | 10,000 | $618,660 | 20,000 | $255,600 |
2022-11 | 0 | $0 | 11,696 | $911,451 | 10,000 | $127,800 |
2022-09 | 0 | $0 | 5,000 | $448,050 | 0 | $0 |
2022-05 | 2,500 | $206,910 | 0 | $0 | 8,000 | $175,360 |
2021-11 | 0 | $0 | 18,995 | $3,083,336 | 17,023 | $901,466 |
2021-08 | 0 | $0 | 8,840 | $969,509 | 9,982 | $537,580 |
2021-05 | 0 | $0 | 0 | $0 | 4,835 | $48,930 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-09-02 | Kozarich John W (Director) | Sale | 467 | 162.76 | 76,008 |
2025-08-01 | Kozarich John W (Director) | Sale | 467 | 131.88 | 61,586 |
2025-07-10 | Kozarich John W (Director) | Sale | 934 | 125.00 | 116,750 |
2025-06-23 | Reardon Andrew (CLO & Secretary) | Sale | 500 | 114.08 | 57,042 |
2025-06-10 | Reardon Andrew (CLO & Secretary) | Sale | 500 | 114.54 | 57,270 |
2025-05-15 | Reardon Andrew (CLO & Secretary) | Sale | 1,000 | 104.00 | 104,000 |
2025-05-09 | Espinoza Octavio (Chief Financial Officer) | Buy | 1,500 | 104.14 | 156,217 |
2025-05-09 | Davis Todd C (Chief Executive Officer) | Buy | 9,510 | 104.92 | 997,827 |
2025-04-01 | Sabba Stephen L | Option Ex | 2,406 | 52.30 | 125,833 |
2025-01-17 | Kozarich John W (Director) | Option Ex | 2,406 | 52.30 | 125,833 |
2024-11-27 | Lamattina John L (Director) | Sale | 2,406 | 123.65 | 297,501 |
2024-11-27 | Lamattina John L (Director) | Option Ex | 2,406 | 52.30 | 125,833 |
2024-09-23 | Reardon Andrew (CLO & Secretary) | Sale | 2,000 | 99.60 | 199,202 |
2024-09-23 | Reardon Andrew (CLO & Secretary) | Option Ex | 2,000 | 52.27 | 104,540 |
2024-09-23 | Korenberg Matthew E (President & COO) | Sale | 9,772 | 101.24 | 989,287 |
2024-09-23 | Korenberg Matthew E (President & COO) | Option Ex | 9,772 | 51.41 | 502,427 |
2024-09-20 | Espinoza Octavio (Chief Financial Officer) | Sale | 1,275 | 103.93 | 132,512 |
2024-09-20 | Korenberg Matthew E (President & COO) | Sale | 6,275 | 104.10 | 653,240 |
2024-09-20 | Korenberg Matthew E (President & COO) | Option Ex | 4,982 | 49.99 | 249,050 |
2024-09-17 | Espinoza Octavio (Chief Financial Officer) | Option Ex | 1,486 | 68.97 | 102,489 |
2024-08-28 | Reardon Andrew (CLO & Secretary) | Sale | 1,500 | 106.39 | 159,591 |
2024-08-28 | Reardon Andrew (CLO & Secretary) | Option Ex | 1,500 | 52.27 | 78,405 |
2024-08-28 | Espinoza Octavio (Chief Financial Officer) | Option Ex | 753 | 63.63 | 47,913 |
2024-08-26 | Korenberg Matthew E (President & COO) | Sale | 11,389 | 105.67 | 1,203,464 |
2024-08-23 | Korenberg Matthew E (President & COO) | Sale | 6,312 | 104.61 | 660,317 |
2024-08-22 | Korenberg Matthew E (President & COO) | Sale | 1,157 | 105.54 | 122,109 |
2024-08-09 | Korenberg Matthew E (President & COO) | Sale | 18,245 | 98.50 | 1,797,132 |
2024-08-08 | Davis Todd C (Chief Executive Officer) | Buy | 2,500 | 97.39 | 243,480 |
2024-05-17 | Espinoza Octavio (Chief Financial Officer) | Sale | 5,156 | 86.66 | 446,803 |
2024-05-17 | Espinoza Octavio (Chief Financial Officer) | Option Ex | 6,917 | 60.60 | 419,204 |
2024-05-16 | Espinoza Octavio (Chief Financial Officer) | Sale | 2,264 | 86.00 | 194,710 |
2024-05-15 | Espinoza Octavio (Chief Financial Officer) | Sale | 5,873 | 86.01 | 505,148 |
2024-05-14 | Korenberg Matthew E (President & Chief Operating) | Sale | 14,158 | 85.38 | 1,208,852 |
2024-05-13 | Korenberg Matthew E (President & Chief Operating) | Sale | 3,440 | 84.54 | 290,827 |
2024-05-09 | Reardon Andrew (Chief Legal Officer &) | Sale | 10,000 | 83.05 | 830,450 |
2024-05-09 | Reardon Andrew (Chief Legal Officer &) | Option Ex | 10,000 | 52.27 | 522,700 |
2024-05-09 | Gray Nancy Ryan (Director) | Sale | 934 | 83.20 | 77,713 |
2024-04-30 | Aryeh Jason (Director) | Option Ex | 2,406 | 52.30 | 125,833 |
2024-04-24 | Kozarich John W (Director) | Option Ex | 2,893 | 39.35 | 113,839 |
2024-03-25 | Davis Todd C (Chief Executive Officer) | Option Ex | 16,015 | 62.03 | 993,490 |
2024-03-05 | Sabba Stephen L | Sale | 1,893 | 74.30 | 140,649 |
2024-03-05 | Sabba Stephen L | Option Ex | 2,893 | .00 | 0 |
2024-02-28 | Espinoza Octavio (Chief Financial Officer) | Sale | 140 | 88.46 | 12,384 |
2024-02-28 | Espinoza Octavio (Chief Financial Officer) | Option Ex | 1,264 | 57.15 | 72,241 |
2023-09-22 | Davis Todd C (CHIEF EXECUTIVE OFFICER) | Buy | 4,000 | 59.38 | 237,528 |
2023-05-16 | Kozarich John W (Director) | Sale | 4,444 | 77.20 | 343,081 |
2023-05-10 | Sabba Stephen L | Sale | 6,408 | 77.13 | 494,223 |
2023-05-10 | Sabba Stephen L | Option Ex | 6,408 | .00 | 0 |
2023-05-08 | Kozarich John W (Director) | Sale | 6,408 | 76.80 | 492,160 |
2023-05-08 | Kozarich John W (Director) | Option Ex | 6,408 | 18.82 | 120,598 |
2023-03-24 | Reardon Andrew (See Remarks) | Sale | 300 | 69.92 | 20,977 |
2022-12-16 | Higgins John L (Director) | Sale | 10,000 | 61.87 | 618,660 |
2022-12-12 | Higgins John L (Director) | Option Ex | 20,000 | 12.78 | 255,600 |
2022-11-18 | Higgins John L (Chief Executive Officer) | Option Ex | 10,000 | 12.78 | 127,800 |
2022-11-17 | Higgins John L (Chief Executive Officer) | Sale | 10,000 | 78.32 | 783,169 |
2022-11-09 | Espinoza Octavio (Chief Financial Officer) | Sale | 1,696 | 75.64 | 128,282 |
2022-09-16 | Higgins John L (Chief Executive Officer) | Sale | 3,000 | 89.35 | 268,050 |
2022-09-15 | Higgins John L (Chief Executive Officer) | Sale | 2,000 | 90.00 | 180,000 |
2022-05-13 | Foehr Matthew W (President and COO) | Buy | 2,500 | 82.76 | 206,910 |
2022-05-09 | Higgins John L (Chief Executive Officer) | Option Ex | 8,000 | 21.92 | 175,360 |
2021-11-16 | Lamattina John L (Director) | Sale | 4,835 | 161.86 | 782,578 |
2021-11-16 | Lamattina John L (Director) | Option Ex | 4,835 | 32.30 | 156,170 |
2021-11-12 | Higgins John L (Chief Executive Officer) | Sale | 3,000 | 160.50 | 481,500 |
2021-11-11 | Foehr Matthew W (President and COO) | Sale | 11,160 | 163.02 | 1,819,258 |
2021-11-11 | Foehr Matthew W (President and COO) | Option Ex | 12,188 | 61.15 | 745,296 |
2021-08-04 | Foehr Matthew W (President and COO) | Sale | 8,840 | 109.67 | 969,509 |
2021-08-04 | Foehr Matthew W (President and COO) | Option Ex | 9,982 | 53.85 | 537,580 |
2021-05-11 | Kozarich John W (Director) | Option Ex | 4,835 | 10.12 | 48,930 |
2021-02-22 | Kozarich John W (Director) | Option Ex | 2,500 | 10.12 | 25,299 |
2021-02-11 | Davis Todd C (Director) | Option Ex | 2,474 | 195.91 | 484,681 |
2021-02-10 | Davis Todd C (Director) | Sale | 5,083 | 213.14 | 1,083,410 |
2021-02-09 | Sabba Stephen L | Sale | 14,670 | 208.28 | 3,055,394 |
2021-02-09 | Sabba Stephen L | Option Ex | 14,670 | 11.32 | 166,137 |
2021-02-05 | Higgins John L (Chief Executive Officer) | Sale | 54,666 | 203.40 | 11,119,228 |
2021-02-05 | Higgins John L (Chief Executive Officer) | Option Ex | 114,666 | 12.26 | 1,405,805 |
2021-02-04 | Berkman Charles S (SVP, Gen. Counsel & Secretary) | Sale | 18,097 | 178.50 | 3,230,368 |
2021-02-04 | Foehr Matthew W (President and COO) | Sale | 44,547 | 176.86 | 7,878,582 |
2021-02-04 | Foehr Matthew W (President and COO) | Option Ex | 45,547 | 48.17 | 2,193,998 |
2021-01-27 | Davis Todd C (Director) | Option Ex | 2,456 | 113.50 | 278,756 |
2021-01-27 | Higgins John L (Chief Executive Officer) | Sale | 40,000 | 182.00 | 7,280,000 |
2021-01-27 | Higgins John L (Chief Executive Officer) | Option Ex | 70,000 | 18.20 | 1,273,650 |
2021-01-25 | Higgins John L (Chief Executive Officer) | Sale | 50,000 | 159.00 | 7,950,000 |
2021-01-25 | Higgins John L (Chief Executive Officer) | Option Ex | 50,000 | 14.47 | 723,500 |
2020-12-08 | Higgins John L (Chief Executive Officer) | Option Ex | 14,657 | 10.05 | 147,302 |
2020-11-09 | Higgins John L (Chief Executive Officer) | Option Ex | 20,000 | 10.05 | 201,000 |
2020-11-02 | Patel Sunil (Director) | Buy | 1,000 | 82.52 | 82,520 |
2020-08-24 | Foehr Matthew W (President and COO) | Sale | 78 | 110.89 | 8,649 |
2020-08-24 | Foehr Matthew W (President and COO) | Option Ex | 78 | 21.92 | 1,709 |
2020-08-21 | Foehr Matthew W (President and COO) | Sale | 7,225 | 112.88 | 815,543 |
2020-08-21 | Foehr Matthew W (President and COO) | Option Ex | 8,015 | 44.45 | 356,226 |
2020-07-07 | Higgins John L (Chief Executive Officer) | Option Ex | 4,315 | 72.16 | 311,357 |
2020-06-04 | Berkman Charles S (SVP, Gen. Counsel & Secretary) | Sale | 11,146 | 118.59 | 1,321,770 |
2020-03-13 | Foehr Matthew W (President and COO) | Option Ex | 2,000 | 21.92 | 43,840 |
2020-02-27 | Foehr Matthew W (President and COO) | Sale | 7,225 | 110.00 | 794,750 |
2020-02-27 | Foehr Matthew W (President and COO) | Option Ex | 8,931 | 18.20 | 162,499 |
2020-02-14 | Foehr Matthew W (President and COO) | Sale | 7,225 | 95.84 | 692,465 |
2020-02-14 | Foehr Matthew W (President and COO) | Option Ex | 7,225 | 14.47 | 104,545 |
2020-02-13 | Foehr Matthew W (President and COO) | Option Ex | 496 | 21.92 | 10,872 |
2020-02-13 | Higgins John L (Chief Executive Officer) | Option Ex | 48,125 | 9.96 | 479,325 |
2019-11-12 | Foehr Matthew W (President and COO) | Option Ex | 1,001 | 21.92 | 21,941 |
2019-09-05 | Foehr Matthew W (President and COO) | Option Ex | 1,005 | 21.92 | 22,029 |
2019-09-03 | Korenberg Matthew E (EVP,Finance & Strategy and CFO) | Buy | 500 | 86.18 | 43,091 |
2019-09-03 | Aryeh Jason (Director) | Buy | 750 | 87.01 | 65,257 |
2019-08-12 | Foehr Matthew W (President and COO) | Option Ex | 1,163 | 21.92 | 25,492 |
2019-08-05 | Berkman Charles S (SVP, Gen. Counsel & Secretary) | Option Ex | 1,093 | 71.03 | 77,630 |
2019-08-05 | Aryeh Jason (Director) | Buy | 746 | 90.01 | 67,145 |
2019-08-02 | Patel Sunil (Director) | Buy | 1,000 | 95.98 | 95,980 |
2019-08-02 | Davis Todd C (Director) | Buy | 1,000 | 93.59 | 93,594 |
2019-08-01 | Lamattina John L (Director) | Option Ex | 2,500 | 32.30 | 80,750 |
2019-07-31 | Sabba Stephen L (Director) | Sale | 4,091 | 94.45 | 386,394 |
2019-07-31 | Aryeh Jason (Director) | Buy | 754 | 93.00 | 70,121 |
2019-07-31 | Higgins John L (Chief Executive Officer) | Buy | 1,850 | 95.45 | 176,582 |
2019-07-30 | Aryeh Jason (Director) | Buy | 3,000 | 100.22 | 300,663 |
2019-07-29 | Aryeh Jason (Director) | Buy | 250 | 106.01 | 26,502 |
2019-06-11 | Aryeh Jason (Director) | Buy | 250 | 107.01 | 26,752 |
2019-06-11 | Foehr Matthew W (President and COO) | Option Ex | 1,004 | 21.92 | 22,007 |
2019-05-31 | Aryeh Jason (Director) | Buy | 500 | 108.51 | 54,255 |
2019-05-31 | Higgins John L (Chief Executive Officer) | Buy | 1,000 | 108.20 | 108,202 |
2019-05-30 | Aryeh Jason (Director) | Buy | 250 | 110.01 | 27,502 |
2019-05-29 | Aryeh Jason (Director) | Buy | 250 | 111.01 | 27,752 |
2019-05-20 | Aryeh Jason (Director) | Buy | 250 | 112.01 | 28,002 |
2019-05-14 | Aryeh Jason (Director) | Buy | 250 | 112.51 | 28,127 |
2019-05-14 | Kozarich John W (Director) | Sale | 2,500 | 112.92 | 282,300 |
2019-05-14 | Kozarich John W (Director) | Option Ex | 2,500 | 17.88 | 44,700 |
2019-05-14 | Higgins John L (Chief Executive Officer) | Buy | 2,500 | 113.50 | 283,750 |
2019-03-14 | Foehr Matthew W (President and COO) | Option Ex | 14,894 | 9.97 | 148,493 |
2019-03-13 | Aryeh Jason (Director) | Buy | 202 | 112.51 | 22,727 |
2019-03-13 | Higgins John L (Chief Executive Officer) | Buy | 2,500 | 114.29 | 285,725 |
2019-01-10 | Berkman Charles S (SVP, Gen. Counsel & Secretary) | Option Ex | 2,850 | 50.87 | 144,970 |
2019-01-10 | Higgins John L (Chief Executive Officer) | Option Ex | 33,790 | 16.14 | 545,370 |
2018-12-17 | Berkman Charles S (SVP, Gen. Counsel & Secretary) | Option Ex | 3,400 | 21.92 | 74,528 |
2018-12-12 | Foehr Matthew W (President and COO) | Option Ex | 7,999 | 9.97 | 79,750 |
2018-10-24 | Berkman Charles S (SVP, Gen. Counsel & Secretary) | Option Ex | 3,900 | 18.20 | 70,960 |
2018-10-12 | Davis Todd C (Director) | Option Ex | 5,083 | 104.53 | 531,300 |
2018-10-11 | Berkman Charles S (SVP, Gen. Counsel & Secretary) | Option Ex | 2,000 | 14.47 | 28,940 |
2018-10-08 | Davis Todd C (Director) | Sale | 2,500 | 253.99 | 634,977 |
2018-10-01 | Foehr Matthew W (President and COO) | Sale | 12,000 | 273.88 | 3,286,560 |
2018-10-01 | Foehr Matthew W (President and COO) | Option Ex | 14,088 | 12.22 | 172,155 |
2018-10-01 | Kozarich John W (Director) | Sale | 2,500 | 275.04 | 687,610 |
2018-09-17 | Berkman Charles S (SVP, Gen. Counsel & Secretary) | Sale | 2,813 | 250.69 | 705,182 |
2018-09-17 | Berkman Charles S (SVP, Gen. Counsel & Secretary) | Option Ex | 2,813 | 100.38 | 282,368 |
2018-09-04 | Sabba Stephen L (Director) | Sale | 5,000 | 255.05 | 1,275,250 |
2018-09-04 | Sabba Stephen L (Director) | Option Ex | 5,000 | 13.23 | 66,150 |
2018-09-04 | Berkman Charles S (SVP, Gen. Counsel & Secretary) | Sale | 19,417 | 254.99 | 4,951,063 |
2018-09-04 | Berkman Charles S (SVP, Gen. Counsel & Secretary) | Option Ex | 19,417 | 59.60 | 1,157,214 |
2018-09-04 | Foehr Matthew W (President and COO) | Sale | 12,000 | 255.01 | 3,060,084 |
2018-09-04 | Foehr Matthew W (President and COO) | Option Ex | 13,044 | 12.22 | 159,397 |
2018-09-04 | Lamattina John L (Director) | Sale | 3,335 | 254.96 | 850,291 |
2018-09-04 | Lamattina John L (Director) | Option Ex | 3,335 | 12.53 | 41,787 |
2018-08-30 | Higgins John L (Chief Executive Officer) | Sale | 3,500 | 258.25 | 903,875 |
Insider trading activities including stock purchases, stock sales, and option exercises of LGND listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ligand Pharmaceuticals Inc (symbol LGND, CIK number 886163) see the Securities and Exchange Commission (SEC) website.